Sildenafil reduces neuroinflammation in cerebellum, restores GABAergic tone, and improves motor in-coordination in rats with hepatic encephalopathy

Fecha de publicación:

Autores de CIPF

  • Ana Agustí Feliu

    Autor

  • Vicente Hernandez Rabaza

    Autor

  • Tiziano Balzano

    Autor

  • Lucas Taoro González

    Autor

  • Andrea Cabrera Pastor

    Autor

  • Santos Fustero Lardies

    Autor

  • Carmina Montoliu Felix

    Autor

Participantes ajenos a CIPF

  • Ibanez-Grau, A

Grupos de Investigación

Abstract

AimsPatients with liver disease may develop hepatic encephalopathy (HE), with cognitive impairment and motor in-coordination. Rats with HE due to portacaval shunts (PCS) show motor in-coordination. We hypothesized that in PCS rats: (i) Motor in-coordination would be due to enhanced GABAergic tone in cerebellum; (ii) increased GABAergic tone would be due to neuroinflammation; (iii) increasing cGMP would reduce neuroinflammation and GABAergic tone and restore motor coordination. To assess these hypotheses, we assessed if (i) treatment with sildenafil reduces neuroinflammation; (ii) reduced neuroinflammation is associated with reduced GABAergic tone and restored motor coordination. MethodsRats were treated with sildenafil to increase cGMP. Microglia and astrocytes activation were analyzed by immunohistochemistry, extracellular GABA by microdialysis, and motor coordination in the beam walking. ResultsPCS rats show neuroinflammation in cerebellum, with microglia and astrocytes activation, increased IL-1b and TNF-a and reduced YM-1 and IL-4. Membrane expression of the GABA transporter GAT1 is reduced, while GAT3 is increased. Extracellular GABA and motor in-coordination are increased. Sildenafil treatment eliminates neuroinflammation, microglia and astrocytes activation; changes in membrane expression of GABA transporters; and restores motor coordination. ConclusionsThis study supports an interplay between cGMP-neuroinflammation and GABAergic neurotransmission in impairing motor coordination in PCS rats.

Datos de la publicación

ISSN/ISSNe:
1755-5930, 1755-5949

CNS Neuroscience & Therapeutics  WILEY

Tipo:
Article
Páginas:
386-394
PubMed:
28296282

Citas Recibidas en Web of Science: 52

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • cGMP; neuroinflammation; GABAergic neurotransmission; GAT3; hepatic encephalopathy; sildenafil

Campos de Estudio

Proyectos asociados

Bases moleculares de las alteraciones neurológicas (cognitivas y motoras) en hiperamonemia y encefalopatía hepática. Implicaciones terapéuticas

Investigador Principal: VICENTE FELIPO ORTS

MINISTERIO DE ECON. Y COMPET. . 2015

Red de Transtornos Adictivos

Investigador Principal: CONSUELO GUERRI SIRERA

INSTITUTO DE SALUD CARLOS III . 2017

Compartir